Non-myeloablative allogeneic stem cell transplantation in children

Haematologica

Volumn 85, Issue 11 SUPPL., 2000, Pages 12-17

  Miniero, R ^a   Zecchina, G ^a   Nagler, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; CHILDHOOD CANCER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; PEDIATRIC SURGERY; T LYMPHOCYTE; THALASSEMIA; WHOLE BODY RADIATION;

CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MYELOABLATIVE AGONISTS;

EID: 0033694540     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Pediatric problems
2. Hematopoietic stem cell transplantation in childhood: Report From the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica
3. Early deaths in children after BMT. Bone Marrow Transplantation Group of the Italian Association for Pediatric Hematology and Oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo (GITMO)
4. Growth and development after hematopoietic cell transplantation
5. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients
6. Marrow ablation: The need for space, immune suppression, and malignant cell eradication
7. Preparative Regimens
8. Conditioning regimens
9. Immunotherapy of leukemia in conjunction with non-myeloablative conditioning: Engraftment of blood stem cells and eradication of host leukemia with non-myeloablative conditioning based on Fludarabine and anti-thymocyte globulin (ATG)
10. Nonmyeloablarive stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
11. Nonmyeloablative preparative regimens: Experimental data and clinical practice
12. Mixed chimerism after transplantation of allogeneic hematopoietic cells
13. Allogeneic cell therapy of severe beta thalassemia major by displacement of host stem cells in mixed chimera by donor blood lymphocytes
14. Hematopoietic cells transplantation for immunodeficiency diseases
15. Marrow transplantation in Thalassemia
16. Rationale and indications for transplantation
17. Management of relapse after hematopoietic cell transplantation
18. Donor leukocytes infusion in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
19. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versusleukemia without myeloablative therapy
20. Transplant-lite induction of Graft-Versus-Malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
21. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias
22. Our-patient PBSC allografts using immunosuppression with low-dose TBI before, and cyclosporine (CSP) and mycophenolate mofetil (MMF) after transplant
23. Mixed lymphohematopoietic chimerism and graft versus lymphoma effect are achievable in adult recipients following nonmyeloablative therapy and HLA-mismatched donor bone marrow transplantation
24. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses
25. Hematopoietic stem cell transplant after reduced intensity conditioning regimen (RI-HSCT): Report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT)
26. Dose-reduced conditioning for allogeneic blood stem cell transplantation: Durable engraftment without antithymocyte globulin
27. Mini-allografts: Ongoing trials in humans
28. Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia
29. Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma
30. Hematopoietic stem cell transplant (HSCT) from HLA matched and mismatched unrelated donors using non-myeloablative regimen
31. Allogeneic hematopoietic stem cell transplantation after immunosuppressive but nonmyeloablative conditioning 'miniallografts' are no small matter
32. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma
33. Matched unrelated bone marrow transplantation using a non-myeloablative conditioning regimen
34. Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease
35. Microchimerism and its role in the induction of transplantation tolerance
36. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
37. A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia
38. Second transplantation using allogeneic peripheral blood stem cells in a b-thalassemia major patient featuring stable mixed chimerism
39. Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi's anemia
40. Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation
41. Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler Syndrome
42. Allografting for high-risk hematological and solid tumors: Reduced intensity chemotherapy followed by reinfusion of lymphocytes engineered with thymidine kinase gene
43. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis